In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors
Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Taha A. Hussien, Esraa A. A. Badr, Tarik A. Mohamed, Hesham R. El‐Seedi, Paul W. Paré, Thomas Efferth, Mohamed‐Elamir F. Hegazy
Topics & Concepts
In silicoCurcuminProteaseLopinavirDocking (animal)ChemistryEnzymeDrug discoveryBiochemistryNatural productActive siteCoronavirusPharmacologyBiologyVirologyCoronavirus disease 2019 (COVID-19)VirusInfectious disease (medical specialty)GeneMedicineViral loadDiseaseAntiretroviral therapyPathologyNursingComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity